Symphony Limited — Updates, 01-08-2025: Press Release

Symphony Limited announced its Q1FY26 financial results, with consolidated revenue down 36% to ₹251 Cr and PAT down 52% to ₹42 Cr, primarily due to seasonal headwinds and a high base. Despite this, it achieved its second-highest June quarter standalone revenue on record. GSK China showed robust growth, repaying ₹27.9 Cr in inter-company loans. A key development: GSK China transferred IPRs to IMPCO Mexico for ~₹44 Cr, with ₹22 Cr received, aiming to boost IMPCO's growth and monetization. An interim dividend of ₹1 per share was approved. Symphony is accelerating its 'Air Force' range and expanding into all-season products, focusing on semi-urban/rural and high-growth export markets.